Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dolomite to Showcase Novel Microfluidic Solutions at MicroTAS 2013

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
Telos and Mitos Dropix to be showcased in Germany from 27th to 31st October.

Dolomite will be showcasing two devices, Telos and Mitos Dropix, on booth #6 at the 17th International Systems for Chemistry and Life Sciences (MicroTAS) in Freiburg, Germany, from the 27th to the 31st October.

The innovative Telos System is a breakthrough product for a wide range of industries requiring a microfluidic device capable of high throughput droplet, particle and flow product generation.

This modular, scalable, and highly flexible technology removes the low throughput limitation of individual microfluidic chips, enabling liters of droplets or particles to be produced in a day.

Each module accommodates a microfluidic chip with up to seven channels and, for maximum throughput, up to 10 modules can be linked to provide a total of 70 parallel channels; with tool-free module assembly and chip connection, set-up is rapid.

Telos features integrated valves for rapid start-up and individual chip control, and operates over a wide range of pressures and temperatures, from 0 to 10bar and 4 to 50°C, providing users with maximum flexibility.

The novel Mitos Dropix, developed in collaboration with the winner of Dolomite’s Productizing Science® Competition 2012, Drop-Tech Ltd, is a flexible, automated solution for droplet-on-demand applications.

Patented droplet ‘picking’ technology enables combinatorial droplet arrays to be created from multiple reagents off-chip and introduced into a flow-through microfluidic system, with accurate control of droplet size and frequency achieved via PC software.

This new high throughput screening format will prove an invaluable resource for basic research, drug discovery, cell-based studies and diagnostics applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!